Authors:
SON KA
MAO AY
KIM BY
LIU F
PYLANT ED
HESS DA
WHITE JM
KWONG DL
ROBERTS DA
VRTIS RN
Citation: Ka. Son et al., ULTRATHIN TA2O5 FILM GROWTH BY CHEMICAL-VAPOR-DEPOSITION OF TA(N(CH3)(2))(5) AND O-2 ON BARE AND SIOXNY-PASSIVATED SI(100) FOR GATE DIELECTRIC APPLICATIONS, Journal of vacuum science & technology. A. Vacuum, surfaces, and films, 16(3), 1998, pp. 1670-1675
Citation: Da. Hess et Mj. Rieder, INTERFERENCE IN IL-2 RECEPTOR-MEDIATED JANUS KINASE ACTIVATION BY THEHYDROXYLAMINE OF SULFAMETHOXAZOLE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 3-3
Citation: Da. Hess et Mj. Rieder, THE ROLE OF REACTIVE DRUG METABOLITES IN IMMUNE-MEDIATED ADVERSE DRUG-REACTIONS, The Annals of pharmacotherapy, 31(11), 1997, pp. 1378-1387
Authors:
ZARI MC
ZWILLING AF
HESS DA
JO J
ANDERSON CS
CHIANG D
Citation: Mc. Zari et al., SOLDIER IDENTIFICATION SYSTEM UTILIZING LOW PROBABILITY OF INTERCEPT (LPI) TECHNIQUES, IEEE aerospace and electronic systems magazine, 12(7), 1997, pp. 21-26
Citation: Da. Hess et al., THE HYDROXYLAMINE OF SULFAMETHOXAZOLE SYNERGIZES WITH FK506 AND CYCLOSPORINE-A, INHIBITING T-CELL PROLIFERATION, The Journal of pharmacology and experimental therapeutics, 281(1), 1997, pp. 540-548
Authors:
HESS DA
ALMAWI WY
PUVANESASINGHAM R
RIEDER MJ
Citation: Da. Hess et al., ALTERED CYTOKINE PRODUCTION INDUCED BY SULFAMETHOXAZOLE HYDROXYLAMINE, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 1-1
Citation: Da. Hess et al., SELECTIVE TOXICITY OF CD8-LYMPHOCTYES BY ME HYDROXYLAMINE METABOLITE OF SULFAMETHOXAZOLE( T), Clinical pharmacology and therapeutics, 59(2), 1996, pp. 10-10
Citation: Da. Hess et al., CYTOKINE MESSENGER-RNA PRODUCTION IS NOT INHIBITED BY IMMUNOSUPPRESSIVE CONCENTRATIONS OF SULFONAMIDE REACTIVE METABOLITES, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 11-11
Citation: Mj. Rieder et al., SELECTIVE ABROGATION OF FK-506 MEDIATED ANTIPROLIFERATIVE EFFECTS OF IL-2 BUT NOT IL-7, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 13-13
Citation: Da. Hess et al., SYNERGISTIC IMMUNOSUPPRESSIVE INTERACTIONS BY HYDROXYLAMINE OF SULFAMETHOXAZOLE (SMX-HA) WITH CYCLOSPORINE-A (CSA), FK-506 AND RAPAMYCIN, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 164-164